GlobeNewswire Inc | Nov 23, 2021 04:01PM EST

November 23, 2021

HAMILTON, Bermuda, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that management will participate in a fireside chat atthe Evercore ISI 4th Annual HealthCONx Conference onTuesday, November 30, 2021 at 12:10 p.m. Eastern Time.

A live webcast of Kiniksas presentation will be accessible through the Investors & Media section of the companys website at www.kiniksa.com. A replay of the webcast will also be available on Kiniksas website within approximately 48 hours after the event.

About KiniksaKiniksa is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksas portfolio of assets, ARCALYST (rilonacept), mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions, and offer the potential for differentiation. These assets are designed to modulate immunological pathways across a spectrum of diseases. For more information, please visitwww.kiniksa.com.

ARCALYSTis a registered trademark ofRegeneron Pharmaceuticals,Inc.

Every Second Counts! ^

Kiniksa Investor and Media Contact Rachel Frank(339) 970-9437rfrank@kiniksa.com